{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:07:30Z","timestamp":1784182050381,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004682","name":"University of Peshawar","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004682","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Applied Radiation and Isotopes"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.apradiso.2026.112778","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:38:26Z","timestamp":1782517106000},"page":"112778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["[225Ac]Ac-Macropa-PEG4-FPA150 enables targeted alpha therapy of B7-H4-Expressing tumors"],"prefix":"10.1016","volume":"236","author":[{"given":"Faiza","family":"Amjad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Qaiser","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apradiso.2026.112778_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.apradiso.2026.112778_bib3","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1021\/jm990141f","article-title":"Improved in vivo stability of actinium-225 macrocyclic complexes","volume":"42","author":"Deal","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.apradiso.2026.112778_bib4","first-page":"4171","article-title":"Dosing 225Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up Yf hematological and renal toxicity","volume":"48","author":"Herrmann","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.apradiso.2026.112778_bib5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2217\/nnm.11.19","article-title":"Nanoparticle PEGylation for improved pharmacokinetics","volume":"6","author":"Jokerst","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.apradiso.2026.112778_bib6","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood.V100.4.1233.h81602001233_1233_1239","article-title":"Targeted \u03b1 particle immunotherapy for myeloid leukemia","volume":"100","author":"Jurcic","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.apradiso.2026.112778_bib7","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2967\/jnumed.116.178673","article-title":"Targeted \u03b1-therapy of metastatic castration-resistant prostate cancer with 225Ac-PSMA-617","volume":"57","author":"Kratochwil","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2026.112778_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.semnuclmed.2020.02.004","article-title":"225Ac-based radioligand therapy of metastatic prostate cancer","volume":"50","author":"Kratochwil","year":"2020","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.apradiso.2026.112778_bib9","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1021\/acs.bioconjchem.0c00171","article-title":"225Ac-H4py4pa for targeted alpha therapy","volume":"32","author":"Li","year":"2021","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.apradiso.2026.112778_bib11","first-page":"109","article-title":"Design and synthesis of 225Ac radioimmunopharmaceuticals","volume":"54","author":"McDevitt","year":"2001","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.apradiso.2026.112778_bib12","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1039\/D3SC06365H","article-title":"Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX","volume":"15","author":"Morgan","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.apradiso.2026.112778_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fmed.2015.00012","article-title":"Introduction to radiobiology of targeted radionuclide therapy","volume":"2","author":"Pouget","year":"2015","journal-title":"Front. Med."},{"key":"10.1016\/j.apradiso.2026.112778_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1039\/C3CS60304K","article-title":"Matching chelators to radiometals for radiopharmaceuticals","volume":"43","author":"Price","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.apradiso.2026.112778_bib15","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.7150\/thno.78043","article-title":"Modulating the pharmacokinetic profile of actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin","volume":"12","author":"Reissig","year":"2022","journal-title":"Theranostics"},{"issue":"15 Suppl. l","key":"10.1016\/j.apradiso.2026.112778_bib16","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2019.37.15_suppl.2529","article-title":"Phase 1a\/1b study of first-in-class B7-H4 antibody, FPA150, as monotherapy in patients with advanced solid tumors","volume":"37","author":"Sachdev","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.apradiso.2026.112778_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00259-018-4167-0","article-title":"225Ac-PSMA-617 in chemotherapy-na\u00efve patients","volume":"46","author":"Sathekge","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.apradiso.2026.112778_bib18","first-page":"459","article-title":"Expression of B7-H4 in human tumors and clinical significance","volume":"20","author":"Schalper","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.apradiso.2026.112778_bib19","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1158\/1078-0432.CCR-23-3746","article-title":"Preclinical efficacy of a PSMA-targeted actinium-225 conjugate (225Ac-macropa-pelgifatamab): a targeted alpha therapy for prostate cancer","volume":"30","author":"Schatz","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.apradiso.2026.112778_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2967\/jnumed.108.058651","article-title":"MIRD pamphlet no. 22: radiobiology and dosimetry of \u03b1-particle emitters for targeted radionuclide therapy","volume":"51","author":"Sgouros","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2026.112778_bib21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1074-7613(03)00152-3","article-title":"B7-H4, a molecule of the B7 family, negatively regulates T cell immunity","volume":"18","author":"Sica","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.apradiso.2026.112778_bib22","doi-asserted-by":"crossref","first-page":"14712","DOI":"10.1002\/anie.201709532","article-title":"An eighteen-membered macrocyclic ligand for actinium-225 targeted alpha therapy","volume":"56","author":"Thiele","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.apradiso.2026.112778_bib23","first-page":"336","article-title":"Actinium-225 for targeted alpha therapy: coordination chemistry and current chelation approaches","volume":"33","author":"Thiele","year":"2018","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.apradiso.2026.112778_bib24","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.apradiso.2026.112778_bib25","first-page":"1338","article-title":"Tumor-associated endothelial expression of B7-H4","volume":"13","author":"Zang","year":"2007","journal-title":"Nat. Med."}],"container-title":["Applied Radiation and Isotopes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804326003623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804326003623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:28:16Z","timestamp":1784179696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969804326003623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":23,"alternative-id":["S0969804326003623"],"URL":"https:\/\/doi.org\/10.1016\/j.apradiso.2026.112778","relation":{},"ISSN":["0969-8043"],"issn-type":[{"value":"0969-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[225Ac]Ac-Macropa-PEG4-FPA150 enables targeted alpha therapy of B7-H4-Expressing tumors","name":"articletitle","label":"Article Title"},{"value":"Applied Radiation and Isotopes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apradiso.2026.112778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112778"}}